Gener8tor — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

CellTrackcelltrackbio.comJul 2026

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days.

BiotechHealthtechMedical DevicesMadison, US

Victor Santoro Fernandes(Founder & CEO)in Reinier Hernandez(Founder & Chief Scientific Advisor)in

BoardRobert Drape(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.